Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 18, 2020Advances in TherapyOpen Access

Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U300 in the Netherlands: Evidence From a Randomised Controlled Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

MEMarc EvansRMRobert Gerald Jan MoesKPKatrine Seide Pedersen

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Evans et al. (2020) studied this question.

synapsesocial.com/papers/6a71cc20f44fa9f079df7fd9https://doi.org/10.1007/s12325-020-01332-y
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 20152016 · 6,744 citations
  2. 2Clinical Inertia in People With Type 2 Diabetes2013 · 596 citations
  3. 3Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries2013 · 169 citations
  4. 4Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study2012 · 665 citations
  5. 5Economic Costs of Diabetes in the U.S. in 20172018 · 2,615 citations